TY - STD TI - OECD. OECD, Health at a Glance 2011: OECD Indicators. Available at URL: http://www.oecd.org/els/health-systems/49105858.pdf UR - http://www.oecd.org/els/health-systems/49105858.pdf ID - ref1 ER - TY - JOUR AU - Mousnad, M. A. AU - Shafie, A. A. AU - Ibrahim, M. I. PY - 2014 DA - 2014// TI - Systematic review of factors affecting pharmaceutical expenditures JO - Health Policy VL - 116 UR - https://doi.org/10.1016/j.healthpol.2014.03.010 DO - 10.1016/j.healthpol.2014.03.010 ID - Mousnad2014 ER - TY - JOUR AU - Garattini, S. AU - Bertele, V. AU - Godman, B. AU - Haycox, A. AU - Wettermark, B. AU - Gustafsson, L. L. PY - 2008 DA - 2008// TI - Enhancing the rational use of new medicines across European health care systems JO - Eur J Clin Pharmacol VL - 64 UR - https://doi.org/10.1007/s00228-008-0537-z DO - 10.1007/s00228-008-0537-z ID - Garattini2008 ER - TY - JOUR AU - Vogler, S. AU - Zimmermann, N. AU - Habl, C. PY - 2013 DA - 2013// TI - Understanding the components of pharmaceutical expenditure - overview of pharmaceutical policies influencing expenditure across European countries JO - GaBi J VL - 2 UR - https://doi.org/10.5639/gabij.2013.0204.051 DO - 10.5639/gabij.2013.0204.051 ID - Vogler2013 ER - TY - JOUR AU - Vogler, S. AU - Zimmermann, N. AU - Leopold, C. AU - Joncheere, K. PY - 2011 DA - 2011// TI - Pharmaceutical policies in European countries in response to the global financial crisis JO - South Med Rev VL - 4 UR - https://doi.org/10.5655/smr.v4i2.1004 DO - 10.5655/smr.v4i2.1004 ID - Vogler2011 ER - TY - JOUR AU - Malmstrom, R. E. AU - Godman, B. B. AU - Diogene, E. AU - Baumgartel, C. AU - Bennie, M. AU - Bishop, I. PY - 2013 DA - 2013// TI - Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs JO - Front Pharmacol VL - 4 UR - https://doi.org/10.3389/fphar.2013.00039 DO - 10.3389/fphar.2013.00039 ID - Malmstrom2013 ER - TY - JOUR AU - Godman, B. AU - Wettermark, B. AU - Woerkom, M. AU - Fraeyman, J. AU - Alvarez-Madrazo, S. AU - Berg, C. PY - 2014 DA - 2014// TI - Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications JO - Front Pharmacol VL - 5 ID - Godman2014 ER - TY - JOUR AU - Weng, T. C. AU - Yang, Y. H. AU - Lin, S. J. AU - Tai, S. H. PY - 2010 DA - 2010// TI - A systematic review and meta-analysis on the therapeutic equivalence of statins JO - J Clin Pharm Ther VL - 35 UR - https://doi.org/10.1111/j.1365-2710.2009.01085.x DO - 10.1111/j.1365-2710.2009.01085.x ID - Weng2010 ER - TY - JOUR AU - Usher-Smith, J. AU - Ramsbottom, T. AU - Pearmain, H. AU - Kirby, M. PY - 2008 DA - 2008// TI - Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on JO - Int J Clin Pract VL - 62 UR - https://doi.org/10.1111/j.1742-1241.2007.01690.x DO - 10.1111/j.1742-1241.2007.01690.x ID - Usher-Smith2008 ER - TY - JOUR AU - Sakshaug, S. AU - Furu, K. AU - Karlstad, O. AU - Ronning, M. AU - Skurtveit, S. PY - 2007 DA - 2007// TI - Switching statins in Norway after new reimbursement policy: a nationwide prescription study JO - Br J Clin Pharmacol VL - 64 UR - https://doi.org/10.1111/j.1365-2125.2007.02907.x DO - 10.1111/j.1365-2125.2007.02907.x ID - Sakshaug2007 ER - TY - JOUR AU - Moon, J. AU - Godman, B. AU - Petzold, M. AU - Alvarez-Madrazo, S. AU - Bennett, K. AU - Bishop, I. PY - 2014 DA - 2014// TI - Different initiatives across Europe to enhance losartan utilisation post generics: impact and implications JO - Front Pharmacol VL - 5 ID - Moon2014 ER - TY - JOUR AU - Martikainen, J. E. AU - Saastamoinen, L. K. AU - Korhonen, M. J. AU - Enlund, H. AU - Helin-Salmivaara, A. PY - 2010 DA - 2010// TI - Impact of restricted reimbursement on the use of statins in Finland: a register-based study JO - Med Care VL - 48 UR - https://doi.org/10.1097/MLR.0b013e3181e41bcb DO - 10.1097/MLR.0b013e3181e41bcb ID - Martikainen2010 ER - TY - JOUR AU - Godman, B. AU - Bishop, I. AU - Finlayson, A. E. AU - Campbell, S. AU - Kwon, H. Y. AU - Bennie, M. PY - 2013 DA - 2013// TI - Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries JO - Expert Rev Pharmacoecon Outcomes Res VL - 13 UR - https://doi.org/10.1586/14737167.2013.820956 DO - 10.1586/14737167.2013.820956 ID - Godman2013 ER - TY - JOUR AU - Woerkom, M. AU - Piepenbrink, H. AU - Godman, B. AU - Metz, J. AU - Campbell, S. AU - Bennie, M. PY - 2012 DA - 2012// TI - Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications JO - J Comp Eff Res VL - 1 UR - https://doi.org/10.2217/cer.12.52 DO - 10.2217/cer.12.52 ID - Woerkom2012 ER - TY - JOUR AU - Godman, B. AU - Wettermark, B. AU - Hoffmann, M. AU - Andersson, K. AU - Haycox, A. AU - Gustafsson, L. L. PY - 2009 DA - 2009// TI - Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance JO - Expert Rev Pharmacoecon Outcomes Res VL - 9 UR - https://doi.org/10.1586/14737167.9.1.65 DO - 10.1586/14737167.9.1.65 ID - Godman2009 ER - TY - JOUR AU - Kaplan, W. A. AU - Ritz, L. S. AU - Vitello, M. AU - Wirtz, V. J. PY - 2012 DA - 2012// TI - Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000–2010 JO - Health Policy VL - 106 UR - https://doi.org/10.1016/j.healthpol.2012.04.015 DO - 10.1016/j.healthpol.2012.04.015 ID - Kaplan2012 ER - TY - JOUR AU - Cameron, A. AU - Ewen, M. AU - Ross-Degnan, D. AU - Ball, D. AU - Laing, R. PY - 2009 DA - 2009// TI - Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(08)61762-6 DO - 10.1016/S0140-6736(08)61762-6 ID - Cameron2009 ER - TY - JOUR AU - Zeng, W. PY - 2013 DA - 2013// TI - A price and use comparison of generic versus originator cardiovascular medicines: a hospital study in Chongqing, China JO - BMC Health Serv Res VL - 13 UR - https://doi.org/10.1186/1472-6963-13-390 DO - 10.1186/1472-6963-13-390 ID - Zeng2013 ER - TY - JOUR AU - Lu, C. AU - Ross-Degnan, D. AU - Stephens, P. AU - Liu, B. AU - Wagner, A. PY - 2013 DA - 2013// TI - Changes in use of antidiabetic medications following price regulations in China (1999–2009) JO - JPHSR VL - 4 ID - Lu2013 ER - TY - JOUR AU - Tang, S. AU - Tao, J. AU - Bekedam, H. PY - 2012 DA - 2012// TI - Controlling cost escalation of healthcare: making universal health coverage sustainable in China JO - BMC Public Health VL - 12 UR - https://doi.org/10.1186/1471-2458-12-S1-S8 DO - 10.1186/1471-2458-12-S1-S8 ID - Tang2012 ER - TY - JOUR AU - Daemmrich, A. AU - Mohanty, A. PY - 2014 DA - 2014// TI - Healthcare reform in the United States and China: pharmaceutical market implications JO - J Pharm Policy Pract VL - 7 UR - https://doi.org/10.1186/2052-3211-7-9 DO - 10.1186/2052-3211-7-9 ID - Daemmrich2014 ER - TY - JOUR AU - Li, X. AU - Zhang, W. PY - 2013 DA - 2013// TI - The impacts of health insurance on health care utilization among the older people in China JO - Soc Sci Med VL - 85 UR - https://doi.org/10.1016/j.socscimed.2013.02.037 DO - 10.1016/j.socscimed.2013.02.037 ID - Li2013 ER - TY - JOUR AU - Meng, Q. AU - Xu, L. AU - Zhang, Y. AU - Qian, J. AU - Cai, M. AU - Xin, Y. PY - 2012 DA - 2012// TI - Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study JO - Lancet VL - 379 UR - https://doi.org/10.1016/S0140-6736(12)60278-5 DO - 10.1016/S0140-6736(12)60278-5 ID - Meng2012 ER - TY - JOUR AU - Barber, S. L. AU - Huang, B. AU - Santoso, B. AU - Laing, R. AU - Paris, V. AU - Wu, C. PY - 2013 DA - 2013// TI - The reform of the essential medicines system in China: a comprehensive approach to universal coverage JO - J Glob Health VL - 3 UR - https://doi.org/10.7189/jogh.03.010303 DO - 10.7189/jogh.03.010303 ID - Barber2013 ER - TY - JOUR AU - Wang, X. Q. AU - Chen, P. J. PY - 2014 DA - 2014// TI - Population ageing challenges health care in China JO - Lancet VL - 383 UR - https://doi.org/10.1016/S0140-6736(14)60443-8 DO - 10.1016/S0140-6736(14)60443-8 ID - Wang2014 ER - TY - JOUR AU - Ling, R. E. AU - Liu, F. AU - Lu, X. Q. AU - Wang, W. PY - 2011 DA - 2011// TI - Emerging issues in public health: a perspective on China’s healthcare system JO - Public Health VL - 125 UR - https://doi.org/10.1016/j.puhe.2010.10.009 DO - 10.1016/j.puhe.2010.10.009 ID - Ling2011 ER - TY - STD TI - National Health and Family Planning Commission of China. China Health Statistics Annuals 2011. Available at URL: http://wsb.moh.gov.cn/htmlfiles/zwgkzt/ptjnj/year2011/index2011.html. UR - http://wsb.moh.gov.cn/htmlfiles/zwgkzt/ptjnj/year2011/index2011.html ID - ref27 ER - TY - JOUR AU - Sun, Q. AU - Santoro, M. A. AU - Meng, Q. AU - Liu, C. AU - Eggleston, K. PY - 2008 DA - 2008// TI - Pharmaceutical policy in China JO - Health Aff VL - 27 UR - https://doi.org/10.1377/hlthaff.27.4.1042 DO - 10.1377/hlthaff.27.4.1042 ID - Sun2008 ER - TY - JOUR AU - Chen, Y. AU - Schweitzer, S. O. PY - 2008 DA - 2008// TI - Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region JO - Value Health VL - 11 UR - https://doi.org/10.1111/j.1524-4733.2008.00376.x DO - 10.1111/j.1524-4733.2008.00376.x ID - Chen2008 ER - TY - JOUR AU - Wagstaff, A. AU - Lindelow, M. PY - 2008 DA - 2008// TI - Can insurance increase financial risk? The curious case of health insurance in China JO - J Health Econ VL - 27 UR - https://doi.org/10.1016/j.jhealeco.2008.02.002 DO - 10.1016/j.jhealeco.2008.02.002 ID - Wagstaff2008 ER - TY - JOUR AU - Li, Y. AU - Xu, J. AU - Wang, F. AU - Wang, B. AU - Liu, L. AU - Hou, W. PY - 2012 DA - 2012// TI - Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids JO - Health Aff (Millwood) VL - 31 UR - https://doi.org/10.1377/hlthaff.2010.0965 DO - 10.1377/hlthaff.2010.0965 ID - Li2012 ER - TY - JOUR AU - Yang, G. AU - Wang, Y. AU - Zeng, Y. AU - Gao, G. F. AU - Liang, X. AU - Zhou, M. PY - 2013 DA - 2013// TI - Rapid health transition in China, 1990–2010: findings from the global burden of disease study 2010 JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(13)61097-1 DO - 10.1016/S0140-6736(13)61097-1 ID - Yang2013 ER - TY - JOUR AU - Yu, X. AU - Li, C. AU - Shi, Y. AU - Yu, M. PY - 2010 DA - 2010// TI - Pharmaceutical supply chain in China: current issues and implications for health system reform JO - Health Policy VL - 97 UR - https://doi.org/10.1016/j.healthpol.2010.02.010 DO - 10.1016/j.healthpol.2010.02.010 ID - Yu2010 ER - TY - JOUR AU - Mao, W. AU - Tang, S. AU - Chen, W. PY - 2013 DA - 2013// TI - Does perverse economic incentive lead to the irrational uses of medicines? JO - Expert Rev Pharmacoecon Outcomes Res VL - 13 UR - https://doi.org/10.1586/14737167.2013.856266 DO - 10.1586/14737167.2013.856266 ID - Mao2013 ER - TY - JOUR AU - Tao, T. AU - Xu, C. AU - Hu, M. AU - Liao, W. AU - Jiang, X. PY - 2011 DA - 2011// TI - Analysis of Chinese pharmaceutical price policy from 1997 to 2011 JO - Chin J Health Policy VL - 4 ID - Tao2011 ER - TY - JOUR AU - Tang, Y. AU - Zhang, X. AU - Yang, C. AU - Yang, L. AU - Wang, H. AU - Zhang, X. PY - 2013 DA - 2013// TI - Application of propensity scores to estimate the association between government subsidy and injection use in primary health care institutions in China JO - BMC Health Serv Res VL - 13 UR - https://doi.org/10.1186/1472-6963-13-183 DO - 10.1186/1472-6963-13-183 ID - Tang2013 ER - TY - JOUR AU - Dylst, P. AU - Vulto, A. AU - Godman, B. AU - Simoens, S. PY - 2013 DA - 2013// TI - Generic medicines: solutions for a sustainable drug market? JO - Appl Health Econ Health Policy VL - 11 UR - https://doi.org/10.1007/s40258-013-0043-z DO - 10.1007/s40258-013-0043-z ID - Dylst2013 ER - TY - JOUR AU - Dylst, P. AU - Vulto, A. AU - Simoens, S. PY - 2014 DA - 2014// TI - Analysis of European policy towards generic medicines JO - GaBi J VL - 3 UR - https://doi.org/10.5639/gabij.2014.0301.011 DO - 10.5639/gabij.2014.0301.011 ID - Dylst2014 ER - TY - JOUR AU - Godman, B. AU - Shrank, W. AU - Andersen, M. AU - Berg, C. AU - Bishop, I. AU - Burkhardt, T. PY - 2010 DA - 2010// TI - Policies to enhance prescribing efficiency in europe: findings and future implications JO - Front Pharmacol VL - 1 ID - Godman2010 ER - TY - JOUR AU - Simoens, S. PY - 2012 DA - 2012// TI - A review of generic medicine pricing in Europe JO - GaBI Journal VL - 1 UR - https://doi.org/10.5639/gabij.2012.0101.004 DO - 10.5639/gabij.2012.0101.004 ID - Simoens2012 ER - TY - STD TI - Yinan B. Radical treatment for healthcare. China Daily. 2010. Available at URL: www.chinadaily.com.cn/china/2010-09/16/content_11309825.htm UR - http://www.chinadaily.com.cn/china/2010-09/16/content_11309825.htm ID - ref41 ER - TY - JOUR AU - Meng, Q. AU - Cheng, G. AU - Silver, L. AU - Sun, X. AU - Rehnberg, C. AU - Tomson, G. PY - 2005 DA - 2005// TI - The impact of China’s retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals JO - Health Policy Plan VL - 20 UR - https://doi.org/10.1093/heapol/czi018 DO - 10.1093/heapol/czi018 ID - Meng2005 ER - TY - JOUR AU - Sun, J. PY - 2013 DA - 2013// TI - International experiences of promoting generics use and its implications to China JO - J Evid Based Med VL - 6 UR - https://doi.org/10.1111/jebm.12030 DO - 10.1111/jebm.12030 ID - Sun2013 ER - TY - JOUR AU - Jiang, Q. AU - Yu, B. N. AU - Ying, G. AU - Liao, J. AU - Gan, H. AU - Blanchard, J. PY - 2012 DA - 2012// TI - Outpatient prescription practices in rural township health centers in Sichuan Province, China JO - BMC Health Serv Res VL - 12 UR - https://doi.org/10.1186/1472-6963-12-324 DO - 10.1186/1472-6963-12-324 ID - Jiang2012 ER - TY - JOUR AU - Chen, C. AU - Dong, W. AU - Shen, J. J. AU - Cochran, C. AU - Wang, Y. AU - Hao, M. PY - 2014 DA - 2014// TI - Is the prescribing behavior of Chinese physicians driven by financial incentives? JO - Soc Sci Med (1982) VL - 120c UR - https://doi.org/10.1016/j.socscimed.2014.05.033 DO - 10.1016/j.socscimed.2014.05.033 ID - Chen2014 ER - TY - JOUR AU - Zeng, W. AU - Zhen, J. AU - Feng, M. AU - Campbell, S. M. AU - Finlayson, A. E. AU - Godman, B. PY - 2014 DA - 2014// TI - Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction JO - J Comp Eff Res VL - 3 UR - https://doi.org/10.2217/cer.14.28 DO - 10.2217/cer.14.28 ID - Zeng2014 ER - TY - JOUR AU - McKeage, K. AU - Blick, S. K. AU - Croxtall, J. D. AU - Lyseng-Williamson, K. A. AU - Keating, G. M. PY - 2008 DA - 2008// TI - Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults JO - Drugs VL - 68 UR - https://doi.org/10.2165/00003495-200868110-00009 DO - 10.2165/00003495-200868110-00009 ID - McKeage2008 ER - TY - JOUR AU - Barkun, A. N. AU - Bardou, M. AU - Kuipers, E. J. AU - Sung, J. AU - Hunt, R. H. AU - Martel, M. PY - 2010 DA - 2010// TI - International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding JO - Ann Intern Med VL - 152 UR - https://doi.org/10.7326/0003-4819-152-2-201001190-00009 DO - 10.7326/0003-4819-152-2-201001190-00009 ID - Barkun2010 ER - TY - JOUR AU - Armstrong, D. PY - 2005 DA - 2005// TI - Intravenous proton pump inhibitor therapy: a rationale for use JO - Rev Gastroenterol Disord VL - 5 ID - Armstrong2005 ER - TY - JOUR AU - Godman, B. AU - Shrank, W. AU - Andersen, M. AU - Berg, C. AU - Bishop, I. AU - Burkhardt, T. PY - 2010 DA - 2010// TI - Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications JO - Expert Rev Pharmacoecon Outcomes Res VL - 10 UR - https://doi.org/10.1586/erp.10.72 DO - 10.1586/erp.10.72 ID - Godman2010 ER - TY - JOUR AU - Jin, S. AU - Zeng, Y. AU - Du, L. AU - Huang, K. PY - 2013 DA - 2013// TI - Analysis of the drug use in 34 hospitals of Chongqing area from 2009 to 2011 JO - China Pharm VL - 24 ID - Jin2013 ER - TY - JOUR AU - Grimshaw, J. AU - Campbell, M. AU - Eccles, M. AU - Steen, N. PY - 2000 DA - 2000// TI - Experimental and quasi-experimental designs for evaluating guideline implementation strategies JO - Fam Pract VL - 17 UR - https://doi.org/10.1093/fampra/17.suppl_1.S11 DO - 10.1093/fampra/17.suppl_1.S11 ID - Grimshaw2000 ER - TY - JOUR AU - Voncina, L. AU - Strizrep, T. AU - Godman, B. AU - Bennie, M. AU - Bishop, I. AU - Campbell, S. PY - 2011 DA - 2011// TI - Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future JO - Expert Rev Pharmacoecon Outcomes Res VL - 11 UR - https://doi.org/10.1586/erp.11.42 DO - 10.1586/erp.11.42 ID - Voncina2011 ER - TY - JOUR AU - Godman, B. AU - Petzold, M. AU - Bennett, K. AU - Bennie, M. AU - Bucsics, A. AU - Finlayson, A. E. PY - 2014 DA - 2014// TI - Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources?: Findings from across Europe and their implications JO - BMC Med VL - 12 UR - https://doi.org/10.1186/1741-7015-12-98 DO - 10.1186/1741-7015-12-98 ID - Godman2014 ER - TY - JOUR AU - Teng, L. AU - Xin, H. W. AU - Blix, H. S. AU - Tsutani, K. PY - 2012 DA - 2012// TI - Review of the use of defined daily dose concept in drug utilisation research in China JO - Pharmacoepidemiol Drug Saf VL - 21 UR - https://doi.org/10.1002/pds.3240 DO - 10.1002/pds.3240 ID - Teng2012 ER - TY - STD TI - Zeng W, Gustafsson LL, Bennie M, Finlayson AE, Godman B. Review of ongoing initiatives to improve prescribing efficiency in China; angiotensin receptor blockers as a case history. Exp Review Pharmacoecon Outcomes Res. 2015;15(1):157–169. ID - ref56 ER - TY - JOUR AU - Zeng, W. AU - Xi, H. AU - Godman, B. AU - Finlayson, A. E. AU - Malmstrom, R. E. PY - 2014 DA - 2014// TI - Ongoing initiatives to improve prescribing efficiency in China; statins as a case history JO - GaBi J VL - 3 UR - https://doi.org/10.5639/gabij.2014.0303.030 DO - 10.5639/gabij.2014.0303.030 ID - Zeng2014 ER - TY - STD TI - WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2013. WHO, Oslo. Available at URL: http://www.whocc.no/atc_ddd_index/. UR - http://www.whocc.no/atc_ddd_index/ ID - ref58 ER - TY - STD TI - World Health Organisation. Introduction to Drug Utilisation Research. WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. ISBN 92 4 156234 X (NLM classification: WB 330). Available at URL: http://apps.who.int/medicinedocs/pdf/s4876e/s4876e.pdf. UR - http://apps.who.int/medicinedocs/pdf/s4876e/s4876e.pdf ID - ref59 ER - TY - JOUR AU - Ronning, M. AU - Blix, H. S. AU - Harbo, B. T. AU - Strom, H. PY - 2000 DA - 2000// TI - Different versions of the anatomical therapeutic chemical classification system and the defined daily dose–are drug utilisation data comparable? JO - Eur J Clin Pharmacol VL - 56 UR - https://doi.org/10.1007/s002280000200 DO - 10.1007/s002280000200 ID - Ronning2000 ER - TY - JOUR AU - Vlahovic-Palcevski, V. AU - Gantumur, M. AU - Radosevic, N. AU - Palcevski, G. AU - Vander Stichele, R. PY - 2010 DA - 2010// TI - Coping with changes in the defined daily dose in a longitudinal drug consumption database JO - Pharm World Sci VL - 32 UR - https://doi.org/10.1007/s11096-010-9366-0 DO - 10.1007/s11096-010-9366-0 ID - Vlahovic-Palcevski2010 ER - TY - JOUR AU - Gustafsson, L. L. AU - Wettermark, B. AU - Godman, B. AU - Andersen-Karlsson, E. AU - Bergman, U. AU - Hasselstrom, J. PY - 2011 DA - 2011// TI - The ‘wise list’- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm JO - Basic Clin Pharmacol Toxicol VL - 108 UR - https://doi.org/10.1111/j.1742-7843.2011.00682.x DO - 10.1111/j.1742-7843.2011.00682.x ID - Gustafsson2011 ER - TY - JOUR AU - Bjorkhem-Bergman, L. AU - Andersen-Karlsson, E. AU - Laing, R. AU - Diogene, E. AU - Melien, O. AU - Jirlow, M. PY - 2013 DA - 2013// TI - Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations JO - Eur J Clin Pharmacol VL - 69 UR - https://doi.org/10.1007/s00228-013-1497-5 DO - 10.1007/s00228-013-1497-5 ID - Bjorkhem-Bergman2013 ER - TY - JOUR AU - Wang, H. AU - Gusmano, M. K. AU - Cao, Q. PY - 2011 DA - 2011// TI - An evaluation of the policy on community health organizations in China: will the priority of new healthcare reform in China be a success? JO - Health Policy VL - 99 UR - https://doi.org/10.1016/j.healthpol.2010.07.003 DO - 10.1016/j.healthpol.2010.07.003 ID - Wang2011 ER - TY - STD TI - Kardakis T, Tomson G, Wettermark B, Brommels M, Godman B, Bastholm-Rahmner P: The establishment and expansion of an innovative centre for rational pharmacotherapy-determinants and challenges. Int J Health Plann Manage 2013. EPub ahead of print ID - ref65 ER - TY - JOUR AU - Forgacs, I. PY - 2008 DA - 2008// TI - Overprescribing proton pump ihhibitors: Is expensive and not evidence based (Editorial) JO - BMJ VL - 336 UR - https://doi.org/10.1136/bmj.39406.449456.BE DO - 10.1136/bmj.39406.449456.BE ID - Forgacs2008 ER - TY - JOUR AU - Jager, C. P. AU - Wever, P. C. AU - Gemen, E. F. AU - Oijen, M. G. AU - Gageldonk-Lafeber, A. B. AU - Siersema, P. D. PY - 2012 DA - 2012// TI - Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia JO - Aliment Pharmacol Ther VL - 36 UR - https://doi.org/10.1111/apt.12069 DO - 10.1111/apt.12069 ID - Jager2012 ER - TY - JOUR AU - Eom, C. S. AU - Jeon, C. Y. AU - Lim, J. W. AU - Cho, E. G. AU - Park, S. M. AU - Lee, K. S. PY - 2011 DA - 2011// TI - Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis JO - CMAJ VL - 183 UR - https://doi.org/10.1503/cmaj.092129 DO - 10.1503/cmaj.092129 ID - Eom2011 ER - TY - JOUR AU - Gray, S. L. AU - LaCroix, A. Z. AU - Larson, J. AU - Robbins, J. AU - Cauley, J. A. AU - Manson, J. E. PY - 2010 DA - 2010// TI - Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the women’s health initiative JO - Arch Intern Med VL - 170 UR - https://doi.org/10.1001/archinternmed.2010.94 DO - 10.1001/archinternmed.2010.94 ID - Gray2010 ER - TY - JOUR AU - Ding, J. AU - Heller, D. A. AU - Ahern, F. M. AU - Brown, T. V. PY - 2014 DA - 2014// TI - The relationship between proton pump inhibitor adherence and fracture risk in the elderly JO - Calcif Tissue Int VL - 94 UR - https://doi.org/10.1007/s00223-014-9855-6 DO - 10.1007/s00223-014-9855-6 ID - Ding2014 ER - TY - JOUR AU - Eom, C. S. AU - Park, S. M. AU - Myung, S. K. AU - Yun, J. M. AU - Ahn, J. S. PY - 2011 DA - 2011// TI - Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies JO - Ann Fam Med VL - 9 UR - https://doi.org/10.1370/afm.1243 DO - 10.1370/afm.1243 ID - Eom2011 ER -